Current Updates on the Use of Probiotics as a New Treatment Option for Multiple Sclerosis (ORP-50)
Multiple sclerosis (MS) is a chronic inflammatory disease that affects the central nervous system and causes nerve demyelination. Although the precise cause of MS is unknown, controlling the immune system and obstructing inflammatory pathways may help manage and treat the condition. According to stu...
Main Authors: | Adrina Habibzadeh, Sara Dehghani, Samin Shiati |
---|---|
Format: | Article |
Language: | English |
Published: |
Iran University of Medical Sciences
2023-01-01
|
Series: | Neurology Letters |
Subjects: | |
Online Access: | https://www.neurologyletters.com/article_184692_d41d8cd98f00b204e9800998ecf8427e.pdf |
Similar Items
-
Gut-Brain axis and MS: Is this true? (ORP-29)
by: Morteza Saeidi
Published: (2023-01-01) -
Multiple Sclerosis—Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics
by: Claudia Mandato, et al.
Published: (2023-06-01) -
Updated Insights into Probiotics and Hepatobiliary Diseases
by: Xiaoyu Xu, et al.
Published: (2024-02-01) -
The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?
by: Hannah M. Kohl, et al.
Published: (2020-08-01) -
The Effect of Probiotic Supplementation on the Gut–Brain Axis in Psychiatric Patients
by: Hussein Sabit, et al.
Published: (2023-05-01)